Joon H. Hwang

Array ( [id] => 2929825 [patent_doc_number] => 05187268 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-16 [patent_title] => 'Gene encoding an anti-complement protein from vaccinia' [patent_app_type] => 1 [patent_app_number] => 7/906983 [patent_app_country] => US [patent_app_date] => 1992-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 2392 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/187/05187268.pdf [firstpage_image] =>[orig_patent_app_number] => 906983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2904022 [patent_doc_number] => 05248666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-28 [patent_title] => 'Methods for inhibiting neoplastic cell proliferation using platelet factor 4' [patent_app_type] => 1 [patent_app_number] => 7/877341 [patent_app_country] => US [patent_app_date] => 1992-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13265 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/248/05248666.pdf [firstpage_image] =>[orig_patent_app_number] => 877341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2915788 [patent_doc_number] => 05206142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-27 [patent_title] => 'Entamoeba histolytica diagnostic assay' [patent_app_type] => 1 [patent_app_number] => 7/874312 [patent_app_country] => US [patent_app_date] => 1992-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6774 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/206/05206142.pdf [firstpage_image] =>[orig_patent_app_number] => 874312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2964382 [patent_doc_number] => 05264550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-23 [patent_title] => 'Human anti-inflammatory phospholipase inhibitor protein' [patent_app_type] => 1 [patent_app_number] => 7/871577 [patent_app_country] => US [patent_app_date] => 1992-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 29 [patent_no_of_words] => 15451 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/264/05264550.pdf [firstpage_image] =>[orig_patent_app_number] => 871577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2969487 [patent_doc_number] => 05202419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-13 [patent_title] => 'Anticoagulative protein PP4-X' [patent_app_type] => 1 [patent_app_number] => 7/841293 [patent_app_country] => US [patent_app_date] => 1992-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3961 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/202/05202419.pdf [firstpage_image] =>[orig_patent_app_number] => 841293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2960668 [patent_doc_number] => 05264357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-23 [patent_title] => 'Nucleic acids vectors and cells for the synthesis of membrane anchor fusion polypeptides' [patent_app_type] => 1 [patent_app_number] => 7/811048 [patent_app_country] => US [patent_app_date] => 1991-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12965 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/264/05264357.pdf [firstpage_image] =>[orig_patent_app_number] => 811048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2945942 [patent_doc_number] => 05180667 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-19 [patent_title] => 'Genes encoding eglin C mutants' [patent_app_type] => 1 [patent_app_number] => 7/776547 [patent_app_country] => US [patent_app_date] => 1991-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8862 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/180/05180667.pdf [firstpage_image] =>[orig_patent_app_number] => 776547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2932529 [patent_doc_number] => 05196403 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-23 [patent_title] => 'Method of inhibiting platelet activation' [patent_app_type] => 1 [patent_app_number] => 7/741403 [patent_app_country] => US [patent_app_date] => 1991-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 12459 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/196/05196403.pdf [firstpage_image] =>[orig_patent_app_number] => 741403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2886925 [patent_doc_number] => 05238839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-24 [patent_title] => 'Nucleic Acids Encoding proteins which induce immunological effector cell activation and chemattraction, vectors, and recombinant cells' [patent_app_type] => 1 [patent_app_number] => 7/732185 [patent_app_country] => US [patent_app_date] => 1991-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 25 [patent_no_of_words] => 24287 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/238/05238839.pdf [firstpage_image] =>[orig_patent_app_number] => 732185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2889151 [patent_doc_number] => 05210027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-11 [patent_title] => 'DNA encoding novel antimicrobial polypeptide and methods for obtaining such polypeptide' [patent_app_type] => 1 [patent_app_number] => 7/730341 [patent_app_country] => US [patent_app_date] => 1991-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3749 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/210/05210027.pdf [firstpage_image] =>[orig_patent_app_number] => 730341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2884679 [patent_doc_number] => 05213980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-25 [patent_title] => 'Fibroblast growth factor gene transformed hybridoma and enhanced production of antibody' [patent_app_type] => 1 [patent_app_number] => 7/706946 [patent_app_country] => US [patent_app_date] => 1991-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5881 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/213/05213980.pdf [firstpage_image] =>[orig_patent_app_number] => 706946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2913770 [patent_doc_number] => 05237056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-17 [patent_title] => 'DNA encoding a protein which copurifies with acetylcholine receptor inducing activity and uses therefor' [patent_app_type] => 1 [patent_app_number] => 7/706872 [patent_app_country] => US [patent_app_date] => 1991-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6582 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/237/05237056.pdf [firstpage_image] =>[orig_patent_app_number] => 706872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2916276 [patent_doc_number] => 05179081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-12 [patent_title] => 'Method of treatment using an anticoagulant polypeptide' [patent_app_type] => 1 [patent_app_number] => 7/693063 [patent_app_country] => US [patent_app_date] => 1991-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 9 [patent_no_of_words] => 9039 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/179/05179081.pdf [firstpage_image] =>[orig_patent_app_number] => 693063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2805564 [patent_doc_number] => 05145962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-08 [patent_title] => 'Human pro relaxin polypeptides' [patent_app_type] => 1 [patent_app_number] => 7/681828 [patent_app_country] => US [patent_app_date] => 1991-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 7485 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/145/05145962.pdf [firstpage_image] =>[orig_patent_app_number] => 681828 [rel_patent_id] =>[rel_patent_doc_number] =>)